Influence of human T-cell lymphotropic virus type 1 (HTLV-1) infection on laboratory parameters of patients with chronic hepatitis C virus

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 51, Issue 6, 2009, Pages 325-329

  Cardoso, Daniela Fernandes ^a   De Souza, Fernando Vieira ^b   Fonseca, Luiz Augusto M ^a   Duarte, Alberto José Da Silva ^a   Casseb, Jorge ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

Author keywords

Coinfection; HCV; Hepatitis C; HTLV 1; Liver enzymes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; GLOBULIN; PLASMA PROTEIN;

ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS TYPE 1 INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LABORATORY TEST; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LYMPHOCYTE COUNT; MALE; MIXED INFECTION; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING HABIT; THROMBOCYTE COUNT; VIRUS TRANSMISSION; BLOOD; CD4 CD8 RATIO; GENETICS; IMMUNOLOGY; MIDDLE AGED; RISK FACTOR;

CD4-CD8 RATIO; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HTLV-I INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 85047681514     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652009000600003     Document Type: Article

References (37)

1. ASSY, N. & MINUK, G.Y. - Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infection in adults. Amer. J. Gastroent., 95: 1545-1550, 2000.
2. BOSCHI-PINTO, C.; STUVER, S.; OKAYAMA, A. et al. - A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan. J. infect. Dis., 181: 35-41, 2000.
3. CHISARI, F.V. - Cytotoxic T cells and viral hepatitis. J. clin. Invest., 99: 1472-1477, 1997.
4. DE LA FLUENTE, L.; TORO, C.; SORIANO, V. et al. - HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates. J. clin. Virol., 35: 244-249, 2006.
5. DE SANTANA, N.P.; DE FREITAS, L.A.; LYRA, A.C. et al. - Liver histological alterations in patients with chronic hepatitis C and normal ALT levels in the city of Salvador, Northeast-Brazil. Braz. J. infect. Dis., 9:134-141, 2005.
6. GORDON, S.C.; FANG, J.W.S.; SILVERMAN, A.L.; McHUTCHINSON, J.G. & ALBRECHT, J.K. - The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C. Hepatology, 32: 400-404, 2000.
7. JAMAL, M.M.; SONI, A.; QUINN, P.G. et al. - Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the southwestern United States. Hepatology, 30:1307-1311, 1999.
8. KAMIHIRA, S.; MOMITA, S.; IKEDA, S. et al. - Cohort study of hepatotropic virus and human T lymphotropic virus type-I infections in an area endemic for adult T cell leukemia. Jap. J. Med., 30: 492-497, 1991.
9. KAWAMURA, T.; FURUSAKA, A.; KOZIEL, M.J. et al. - Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology, 25: 1014-1021, 1997.
10. KERR, J.F.R.; COOKSLEY, W.G.; SEARLE, J. et al. - The nature of piecemeal necrosis in chronic active hepatitis. Lancet, 2(8147): 827-828, 1979.
11. KISHIHARA, Y.; FURUSYO, N.; KASHIWAGI, K. et al. - Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance. J. infect. Dis., 184: 1114-1119, 2001.
12. LAUER, G.M. & WALKER, B.D. - Hepatitis C virus infection. New Engl. J. Med., 345: 41-52, 2001.
13. LEFKOWITCH, J.H. - Liver biopsy assessment in chronic hepatitis. Arch. med. Res., 38: 634-643, 2007.
14. LIANG, T.J.; REHERMANN, B.; SEEF, L.B. & HOOFNAGLE, J.H. - Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. intern. Med., 132: 296-305, 2000.
15. MARCELLIN, P.; ASSELAH, T. & BOYER, N. - Fibrosis and disease progression in hepatitis C. Hepatology, 36 (5 suppl. 1): S47-S56, 2002.
16. MATHURIN, P.; MOUSSALLI, J.; CADRANEL, J.F. et al. - Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanina transaminases activity. Hepatology, 27: 868-872, 1998.
17. MEMON, M.I. & MEMON, M.A. - Hepatitis C: an epidemiologic review. J. viral Hepat., 9: 84-100, 2002.
18. MODI, A.A. & LIANG, T.J. - Hepatitis C: a clinical review. Oral Dis., 14: 10-14, 2008.
19. MURAI, K.; TACHIBANA, N.; SHIOIRI, S. et al. - Suppression of delayed-type hypersentivity to PPD and PHA in elderly HTLV-I carriers. J. acquir. immune Defic. Syndr., 3: 1006-1009, 1990.
20. NAOUMOV, N.V. - Hepatitis C virus-specific CD4+ T cells: do they help or damage? Gastroenterology, 117: 1012-1014, 1999.
21. OSAME, M.; USUKU, K.; IZUMO, K. et al. - HTLV-I associated myelopathy, a new clinical entity. Lancet, 1(8488): 1031-1032, 1986.
22. PAWLOTSKY, J.M. - Therapy of hepatitis C: from empiricism to eradication. Hepatology, 43(2 suppl. 1): S207-S220, 2006.
23. POYNARD, T.; BEDOSSA, P. & OPOLON, P. - Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet, 349(9055): 825-832, 1997.
24. PRESSIONE, F.; RAMOND, M.J.; NJAPOUM, C. et al. - Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology, 34: 121-125, 2001.
25. SHEPARD, C.W.; FINELLI, L. & ALTER, M.J. - Global epidemiology of hepatitis C virus infection. Lancet infect. Dis., 5: 558-567, 2005.
26. SHERLOCK, S. & DOOLEY, J. - Diseases of the liver and biliary system. 11. ed. Rio de Janeiro, Guanabara Koogan, 2004.
27. SHINDO, M.; ARAI, K.; SOKAWA, Y.S. & OKUNO, T. - The virological and histological states of anti-hepatitis C virus-positive subjets with normal biochemical values. Hepatology, 22: 418-425, 1995
28. SILVA, I.S.S.; FERRAZ, M.L.C.G.; PEREZ, R.M. et al. - Role of gamma-glutamyl transferase activity in patients with chronic hepatitis C virus infection. J. Gastroent. Hepat., 19: 314-318, 2004.
29. SIMMONDS, P.; BUKH, J.; COMBET, C. et al. - Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology, 42: 962-973, 2005.
30. STUVER, S.O.; BOSCHI-PINTO, C.; OKAYAMA, A. & MUELLER, N. - Author reply. J. infect. Dis., 182: 379-380, 2000.
31. TACHIBANA, N.; OKAYAMA, A.; ISHIZAKI, J. et al. - Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan. Int. J. Cancer., 42: 829-831, 1988.
32. TAKAKU, S.; NAKAGAWA, Y.; SHIMIZU, M. et al. - Induction of hepatic injury by hepatitis C virus specific CD8 (+) murine cytotoxic lymphocytes in transgenic mice expressing the viral structural genes. Biochem. Biophys. Res. Commun., 301: 330-337, 2003.
33. URETA-VIDAL, A.; PIQUE, C.; GARCIA, Z. et al. - Human T-cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T Iymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers. J. infect. Dis., 183: 857-864, 2001.
34. WAKITA, T.; KATSUME, A.; KATO, J. et al. - Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA mice mediated by Cre/loxP system. J. med. Virol., 62: 308-317, 2000.
35. WELLES, S.L.; TACHIBANA, N.; OKAYAMA, A. et al. - Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int. J. Cancer, 56: 337-340, 1994.
36. YOSHIDA, M.; MIYOSHI, I. & HINUMA, Y. - Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. nat. Acad. Sci. (Wash.), 79: 2031-2035, 1982.
37. ZECHINI, B.; PASQUAZZI, C. & ACETI, A. - Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression. Europ. J. Gastroent. Hepat., 16: 891-896, 2004.